Division of Allergy and Clinical Immunology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Allergy Asthma Immunol Res. 2011 Apr;3(2):67-73. doi: 10.4168/aair.2011.3.2.67. Epub 2011 Feb 14.
Atopic dermatitis (AD) is an inflammatory disease characterized by pruritic skin lesions. The pathogenesis of AD may include disrupted epidermal barrier function, immunodysregulation, and IgE-mediated sensitization to food and environmental allergens. AD is also part of a process called the atopic march, a progression from AD to allergic rhinitis and asthma. This has been supported by multiple cross-sectional and longitudinal studies and experimental data. Research on the mechanisms of AD has been centered on the adaptive immune system with an emphasis on the T-helper 1 (Th1)-Th2 paradigm. Recently, the conceptual focus has largely shifted to include a primary defect in the epithelial barrier as an initial event in AD providing a significant insight into the disease initiation and pointing to a complex secondary interplay of environmental and immunological sequelae with barrier disruption. Further understanding of AD will help the development of more effective treatment for AD and ultimately, preventative algorithms for the atopic march. In this review we highlight recent advances in our understanding of the pathogenesis of AD and the atopic march.
特应性皮炎(AD)是一种炎症性疾病,其特征为瘙痒性皮损。AD 的发病机制可能包括表皮屏障功能紊乱、免疫失调以及对食物和环境变应原的 IgE 介导致敏。AD 也是特应性进程的一部分,即从 AD 到过敏性鼻炎和哮喘的进展。这一观点得到了多项横断面和纵向研究以及实验数据的支持。AD 发病机制的研究主要集中在适应性免疫系统上,重点是 T 辅助细胞 1(Th1)-Th2 范式。最近,概念重点已很大程度上转移到将上皮屏障的主要缺陷作为 AD 的初始事件,这为疾病的启动提供了重要的见解,并指向了环境和免疫后果与屏障破坏的复杂二次相互作用。进一步了解 AD 将有助于开发更有效的 AD 治疗方法,并最终为特应性进程制定预防算法。在这篇综述中,我们重点介绍了我们对 AD 发病机制和特应性进程的理解的最新进展。